AbCellera to release Phase 2 top-line data for ABCL635 (menopause VMS) on Aug 10, 2026

AbCellera Biologics Inc.

Top-line data from Phase 2 trial of ABCL635 for moderate-to-severe vasomotor symptoms due to menopause to be released before market open on Monday, August 10, 2026.
Investor conference call and webcast scheduled at 4:30 a.m. PT / 7:30 a.m. ET on the same day.
No trial results disclosed in this announcement; data release is upcoming catalyst.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.